| Mast cells as targets for immunotherapy of solid tumors SA Oldford, JS Marshall Molecular immunology 63 (1), 113-124, 2015 | 182 | 2015 |
| A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth SA Oldford, ID Haidl, MA Howatt, CA Leiva, B Johnston, JS Marshall The Journal of Immunology 185 (11), 7067-7076, 2010 | 156 | 2010 |
| Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients SA Oldford, JD Robb, D Codner, V Gadag, PH Watson, S Drover International immunology 18 (11), 1591-1602, 2006 | 129 | 2006 |
| Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4 A Al-Afif, R Alyazidi, SA Oldford, YY Huang, CA King, N Marr, ID Haidl, ... Journal of Allergy and Clinical Immunology 136 (5), 1346-1354. e1, 2015 | 57 | 2015 |
| HLA antigen changes in malignant tumors of mammary epithelial origin: molecular mechanisms and clinical implications M Campoli, CC Chang, SA Oldford, AD Edgecombe, S Drover, S Ferrone Breast disease 20 (1), 105-125, 2004 | 38 | 2004 |
| HLA‐DRB alleles are differentially expressed by tumor cells in breast carcinoma SA Oldford, JD Robb, PH Watson, S Drover International journal of cancer 112 (3), 399-406, 2004 | 37 | 2004 |
| Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice A Vila-Leahey, SA Oldford, PA Marignani, J Wang, ID Haidl, JS Marshall Oncoimmunology 5 (7), e1151591, 2016 | 35 | 2016 |
| Ranitidine inhibition of breast tumor growth is B cell dependent and associated with an enhanced antitumor antibody response D Rogers, A Vila-Leahey, AC Pessôa, S Oldford, PA Marignani, ... Frontiers in immunology 9, 395265, 2018 | 16 | 2018 |
| Interferon α2 and interferon γ induce the degranulation independent production of VEGF‐A and IL‐1 receptor antagonist and other mediators from human mast cells SA Oldford, SP Salsman, L Portales‐Cervantes, R Alyazidi, R Anderson, ... Immunity, inflammation and disease 6 (1), 176-189, 2018 | 14 | 2018 |
| Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes DR Spurrell, SA Oldford, T Frost, B Larsen, D Codner, A Edgecombe, ... Human immunology 65 (12), 1516-1529, 2004 | 9 | 2004 |
| Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus … MK Foley, SD Searle, A Toloue, R Booth, A Falkenham, D Falzarano, ... EClinicalMedicine 37, 2021 | 8 | 2021 |
| Histamine receptor 2 blockade selectively impacts B and T cells in healthy subjects D Meghnem, SA Oldford, ID Haidl, L Barrett, JS Marshall Scientific Reports 11 (1), 9405, 2021 | 7 | 2021 |
| Early Immune Changes during HCV DAA Therapy in an Incarcerated Population SA Oldford, K Arseneault, L Barrett Journal of Hepatology 2 (64), S525-S526, 2016 | 2 | 2016 |
| Mast cell modulation of the tumor microenvironment SA Oldford, JS Marshall The Tumor Immunoenvironment, 479-509, 2013 | 2 | 2013 |
| Comprehensive immune changes associated with HCV direct-acting antiviral cures D Slauenwhite, K Arseneault, C Brisseau, S Oldford, L Barrett Journal of Hepatology 1 (66), S538-S539, 2017 | 1 | 2017 |
| Histamine receptor 2 blockade reduces breast tumor development and metastasis (TUM9P. 1010) A Vila-Leahey, S Oldford, P Marignani, J Marshall The Journal of Immunology 194 (1_Supplement), 210.12-210.12, 2015 | 1 | 2015 |
| Interrelationships and clinical significance of expression of immunological markers in invasive breast carcinoma SA Oldford Memorial University of Newfoundland, 2006 | 1 | 2006 |
| HEPATITIS C TREATMENT AND BARRIERS TO CARE IN NOVA SCOTIAN VULNERABLE POPULATIONS S Davis, B Goodall, Y Lynch-Hill, A Dutin, S Oldford, L Barrett HEPATOLOGY 72, 562A-562A, 2020 | | 2020 |
| A FRAMEWORK FOR COMMUNITY EMBEDDED HEPATITIS C ELIMINATION RESEARCH: ENGAGING VULNERABLE POPULATIONS J Dirk, B Goodall, S Oldford, N Bartlett, L Barrett HEPATOLOGY 70, 375A-375A, 2019 | | 2019 |
| RAPID VIRAL SUPPRESSION AND FREQUENT HCV CURE IN CORRECTIONS EXPERIENCED INDIVIDUALS IN CORRECTIONAL OR COMMUNITY SETTINGS B Goodall, C Ramsay, S Greenan, N Bartlett, S Oldford, L Barrett HEPATOLOGY 70, 976A-976A, 2019 | | 2019 |
